Departure. Clinical Miss. Billion: Should You Bet on Pfizer?
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Learn where to look for investment opportunities that can lead to substantial financial growth. Discover places to start your search.
21,370 articlesPfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
A July 2026 mid-year review spots Coca-Cola, Procter & Gamble, and Johnson & Johnson as the leading dividend aristocr...
Bitcoin has retraced from its peak, triggering nerves for many investors. This article uses historical cycles to expl...
Palantir faced a sharp 34% drop in the first half of 2026 as AI market expectations and earnings jitters weighed on s...
A record quarterly wave of AI data-center disruption worth about $130 billion has sparked a fresh warning from Mark C...
Micron has bounced around the market, but its long-term growth story is coming into sharper focus. This article expla...
Space-based connectivity is drawing attention to AST SpaceMobile. This article analyzes potential price trajectories,...
Airgain's 2025 earnings outlook hinges on product mix, OEM momentum, and margin discipline. This guide breaks down th...
Rigetti Computing releases Q4 2025 results after hours, showing revenue near 2.3 million and a continued loss as it a...
Two AI infrastructure players, CoreWeave and Nebius, face off as compute demand climbs. This guide breaks down backlo...
In early 2026, brokerages began shifting recruitment emphasis from commission splits to culture, mentorship, and infr...
Many workers find themselves taking on tasks they didn’t apply for, often with no raise or promotion in sight. This a...